NETWORKING LUNCH BREAK - POSTERS, EXHIBITS AND HUBTALKS
HT-16 - SHIFTING THE PARADIGM: NOVEL APPROACHES ADDRESSING ALDOSTERONE IN RESISTANT AND UNCONTROLLED HYPERTENSION
Saturday, October 25, 2025
1:40pm - 2:00pm ET
Room: Theatre 3
Sponsored By
Step into the future of hypertension care with “Shifting the Paradigm: Novel Approaches Addressing Aldosterone in Resistant and Uncontrolled Hypertension.” This session will examine how aldosterone contributes to the complexity of difficult-to-control hypertension and discuss the potential role of targeting this pathway as a new management strategy. Explore the latest clinical evidence, from established therapies to innovative new treatments, that are transforming care for resistant and uncontrolled hypertension. Beyond the science, gain practical insights into integrated approaches that streamline blood pressure management, enhance coordination across the care team, and help you optimize outcomes for patients with uncontrolled and resistant hypertension.
Learning Objectives:
At the end of this session participants will be able to:
Examine the underlying mechanisms by which aldosterone drives the pathogenesis and persistence of uncontrolled and resistant hypertension;
Assess the clinical evidence for both established and novel therapeutic strategies that target the aldosterone pathway in resistant and uncontrolled hypertension; and
Discuss integrated and streamlined approaches to hypertension management to enhance treatment optimization.
